- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gritstone Oncology Inc (GRTSQ)
"Gritstone Oncology Inc stock price live, this page displays OTC GRTSQ stock exchange data. View the GRTSQ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Gritstone Oncology Inc real time stock price chart below.
What Is the Gritstone Oncology Inc Stock Price Today?
The Gritstone Oncology Inc stock price today is 0.003.
What Is the Stock Symbol for Gritstone Oncology Inc?
The stock symbol for Gritstone Oncology Inc is ""GRTSQ.""
What Stock Exchange Does Gritstone Oncology Inc Trade On?
Gritstone Oncology Inc is listed and trades on the OTC Markets stock exchange.
Is Gritstone Oncology Inc a Good Stock to Buy?
Determining whether Gritstone Oncology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRTSQ quote. (ISIN: US39868T1051)"
What Is the Gritstone Oncology Inc Stock Price Today?
The Gritstone Oncology Inc stock price today is 0.003.
What Is the Stock Symbol for Gritstone Oncology Inc?
The stock symbol for Gritstone Oncology Inc is ""GRTSQ.""
What Stock Exchange Does Gritstone Oncology Inc Trade On?
Gritstone Oncology Inc is listed and trades on the OTC Markets stock exchange.
Is Gritstone Oncology Inc a Good Stock to Buy?
Determining whether Gritstone Oncology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRTSQ quote. (ISIN: US39868T1051)"
OTC Markets
Currency in USD
0.003
0.000(0.00%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.003
0.003
52 wk Range
0.001
2.940
GRTSQ Scorecard
Full Analysis
Operates with a significant debt burden
Earnings results expected today
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0030.003
52 wk Range
0.0012.940
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GRTSQ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Gritstone Oncology Inc Company Profile
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, an individualized immunotherapy candidate, which is in Phase 2/3 clinical trials for the treatment of microsatellite stable colorectal cancers; and has completed Phase 1/2 clinical trials for treating solid tumors. The company is also developing SLATE, an off-the-shelf immunotherapy candidate, which is in Phase 2 clinical trials for the treatment of metastatic solid tumors. In addition, it develops CORAL, a COVID-19 vaccine program; and a therapeutic vaccine candidate that is in Phase 1 clinical trials designed to treat and cure human immunodeficiency virus (HIV) infection. Gritstone bio, Inc. has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California. On October 10, 2024, Gritstone bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Gritstone Oncology Inc SWOT Analysis
GRANITE's Promise | Explore Gritstone's pivotal GRANITE program for colorectal cancer, with key Phase 2 trial results expected in Q3 2024, potentially revolutionizing cancer treatment |
Financial Outlook | Gritstone's $85.3M cash position supports operations through Q4 2024, with analysts setting a $5 price target amidst current market challenges |
Beyond Cance | Delve into Gritstone's diverse pipeline, including a COVID-19 vaccine candidate and potential government funding, showcasing the company's versatile platform |
Risk vs. Reward | Uncover the critical factors influencing Gritstone's future, from upcoming clinical data to funding needs, in a comprehensive SWOT analysis of this innovative biotech |
Gritstone Oncology Inc Earnings Call Summary for
- GRANITE program shows positive PFS trend in colorectal cancer, with hazard ratios of 0.82 overall and 0.52 in high-risk patients
- Q1 net loss of $40.4M; cash position of $52.8M after public offering and workforce reduction extends runway to Q4 2024
- Mature PFS data expected Q3 2024; FDA discussions on phase three endpoints planned
- BARDA talks ongoing for Phase 2b COVID-19 vaccine study; potential partnerships in sight
- Company focuses on PFS improvement, particularly in low ctDNA patients; pursuing adjuvant indications for earlier stage trials
Last Updated: 2024/05/11, 16:14
Read Full TranscriptCompare GRTSQ to Peers and Sector
Metrics to compare | GRTSQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRTSQPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −0.9x | −0.5x | |
PEG Ratio | 0.00 | −0.02 | 0.00 | |
Price/Book | 0.0x | 0.7x | 2.6x | |
Price / LTM Sales | 0.0x | 4.2x | 3.0x | |
Upside (Analyst Target) | - | 328.0% | 54.7% | |
Fair Value Upside | Unlock | 27.4% | 9.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.000
Earnings
Latest Release
Nov 07, 2024
EPS / Forecast
-0.17 / -0.185
Revenue / Forecast
-- / --
FAQ
What Is the Gritstone Oncology (GRTSQ) Stock Price Today?
The Gritstone Oncology stock price today is 0.003
What Stock Exchange Does Gritstone Oncology Trade On?
Gritstone Oncology is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Gritstone Oncology?
The stock symbol for Gritstone Oncology is "GRTSQ."
What Is the Gritstone Oncology Market Cap?
As of today, Gritstone Oncology market cap is 443.13K.
What is Gritstone Oncology Earnings Per Share?
The Gritstone Oncology EPS is -1.08.
What Is the Next Gritstone Oncology Earnings Date?
Gritstone Oncology will release its next earnings report on 24 Mar 2025.
From a Technical Analysis Perspective, Is GRTSQ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.